Iovance's stock slides 40% after sharing data about its melanoma therapy - MarketWatch

Shares of Iovance Biotherapeutics Inc. undefined tumbled about 40% in after-hours trading on Thursday. The company had announced new clinical data for its...

Shares of Iovance Biotherapeutics Inc. IOVA, +2.30% tumbled about 40% in after-hours trading on Thursday. The company had announced new clinical data for its experimental melanoma drug, includi… [+403 chars]

full article...